EnCompass Technologies
Focus: EnCompass Technologies develops the F2 Filter and Delivery System, a device designed to protect the brain during cardiac surgery, particularly in aortic stenosis interventions. The company operates in the niche intersection of neurology and cardiovascular care with an early-stage device platform.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About EnCompass Technologies
AI assessmentNot HiringNo open roles listed right now. Follow EnCompass Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
F2 Filter and Delivery System
Aortic Stenosis Treated With TAVIClinical Trials (1)
NCT06689839Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
N/AHelp build intelligence for EnCompass Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.